Supervised aerobic exercise for people with lymphoma

Evidence label: Positive randomized supportive-care evidence · Clinical goal: improve physical function and quality of life during or after lymphoma treatment

Evidence at a glance

Population: 122 people with lymphoma, stratified by lymphoma type and current treatment status.
Intervention: 12 weeks of supervised aerobic exercise, compared with usual care.
Result: patient-rated physical function improved by 9 points relative to control, with benefits in fitness, fatigue and quality of life.

What was studied

A Canadian randomized trial assigned 60 participants to supervised aerobic training and 62 to usual care. Ninety-six percent completed the immediate postintervention assessment. The primary outcome was patient-rated physical functioning; fitness and several quality-of-life measures were secondary.

What the evidence shows

At 12 weeks, the adjusted physical-function difference favored exercise by 9.0 points (95% CI 2.0 to 16.0; P=.012). Overall quality of life, fatigue, cardiovascular fitness and lean body mass also favored exercise. The program did not interfere with chemotherapy completion or treatment response in this trial.

These are function and symptom findings. The study was not designed to prove better lymphoma control or survival.

Limits and uncertainty

The trial came from one region, included different lymphoma types and mixed on-treatment and off-treatment participants. Supervised aerobic training may not generalize to unsupervised programs. Many secondary outcomes were tested, and treatment-response comparisons were not the primary efficacy question.

Safety and practical context

Lymphoma treatment can cause anemia, infection risk, neuropathy and cardiopulmonary limitations. Intensity may need adjustment around cytopenias, fever, cardiotoxic therapy or active complications. New chest pain, syncope or fever should not be managed by exercising through it.

Questions for the care team

Does my lymphoma treatment create cardiac, infection or blood-count restrictions?
Would supervised aerobic training be safer than starting alone?
How should fatigue and physical function be measured over 12 weeks?

Sources

Lymphoma aerobic-exercise randomized trial (PMID 19687337)

Literature searched: October 22, 2026 · Record appraised: October 22, 2026

Educational evidence summary, not personal medical advice. Research regimens describe what was studied; they are not personal prescribing instructions and should not replace cancer treatment or individualized supportive care.